ARCHIVES

ODAC Unanimously Rejects Melblez, Citing Lower Survival

This article is from The Cancer Letter archive.

Vol. 39 No. 20 | May 17, 2013

Download PDF Visit The Full Archive

Related Articles

Oncology Unit – How To Plan, Start It

February 10, 1978

Interview: “People don’t understand Clinical Trials.

September 5, 1997

Challoner: We Recommended FDA Replace 510(k) Clearance

July 4, 2014

In Brief: George Vande Woude Of NCI Named PI for Litton Bionetics Basic Research Contract At Frederick

September 23, 1983

ECOG, ACRIN Agree To Join; NCI’s Goal Of Four Adult Groups Is One Merger Away

March 18, 2011

CHOP Evaluation Plan In Jan. 22 Issue

January 15, 1982